Improving outcomes for children with sarcoma cancers
News Stories
Luminesce Alliance is supporting a Phase I clinical trial to evaluate administration of EphA2 targeted CAR T-cells to children with sarcoma.
The trial, at the Children’s Cancer Research Unit led by Professor Geraldine O’Neill at the Children’s Hospital at Westmead, aims to address critical knowledge gaps in children’s sarcoma cancer treatment.
The trial contributes to the broader understanding of the feasibility and challenges of using CAR T-cell therapy to inform the next generation of clinical trials.